IconOVir Bio
Next-generation oncolytic virus therapies for solid tumors.
San Diego, United States · Founded 2018 · $97.2M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- iconovir.com
- Total Funding
- $97.2M
- Last Round
- $20.2M Venture RoundJun 2024
- Rounds
- 2
About
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy for the treatment of cancer. Its proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O'Shea, Ph.D., of the Salk Institute, and is designed to selectively replicate within and destroy tumor cells while sparing normal tissue. The company was founded by Two River Group, chaired by Arie Belldegrun, M.D., FACS — the team behind Kite Pharma and Allogene Therapeutics — and is focused on developing next-generation oncolytic viruses engineered for superior potency and immune engagement in solid tumors.
Summary
IconOVir Bio is a Biotech company based in San Diego, United States, founded in 2018. It has raised $97.2M in total across 2 rounds, most recently a $20.2M Venture Round round in Jun 2024. Investors include Vida Ventures, Nextech Invest and Two River Group.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2024
Sign up to see all 2 rounds
Series A through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/iconovir-bio"><img src="https://indexed.vc/api/badge/company/iconovir-bio" alt="IconOVir Bio on Indexed.vc" width="260" height="76" /></a>